Electrocore Inc ECOR

$7.23 +0.07 (0.98%)

Valuation

Market cap
67,799,000
Revenue TTM
$32,030,000
Net income TTM
$-13,970,000
P/E (trailing)
0.00
P/E (forward)
—
Profit margin
-43.62%
Debt to equity
-2.07

Trading

Volume
125,900
Avg volume
80,080
Day's range
$6.93 – $7.41
Shares out
9,016,000
Stochastic %K
10%
Beta
1.05
Analysts
Strong Buy
Price target
$18.96

Price

Company profile

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as...

Show more

electroCore, Inc., a bioelectronic technology medicine and general wellness company, provides non-invasive vagus nerve stimulation (nVNS) technology platform in the United States, the United Kingdom, and internationally. The company develops gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga 350, a personal use consumer electronics general wellness product and Truvaga Plus, an app-enabled general wellness product. It also offers non-invasive bioelectronic therapies for the treatment of chronic pain and wellness conditions. In addition, the company offers TAC-STIM for human performance and gammaCore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Industry
Medical Devices
Sector
Healthcare
Phone
888 903 2673
Website
https://www.electrocore.com
Address
200 Forge Way, Suite 205, Rockaway, United States

Latest news

Stocktwits

LewisDaKat Oct 29, 5:30 PM
$ECOR electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026 https://marketwirenews.com/stock/ecor/news/electrocore-to-announce-third-quarter-september-30-2-5349690838550249.html?utm_source=stocktwits
0 replies
taxplanr Oct 28, 1:16 PM
$ECOR Quell submitted to FDA for relieving chemo side effects https://investor.electrocore.com/news-releases/news-release-details/electrocore-inc-submits-510k-premarket-notification-fda-seeking
0 replies
taxplanr Oct 22, 1:54 PM
$ECOR this sell off looked like another ATM maneuver
0 replies
taxplanr Oct 7, 4:31 PM
There's so much more that $ECOR can treat with Gammacore and Truvaga Plus PEMF devices https://www.tiktok.com/t/ZPLYCFrmN/
0 replies
taxplanr Oct 7, 2:52 PM
Will $ECOR ever go after the full PEMF market beyond the vagus nerve? https://youtu.be/SHEezTsWeLE?si=0OyEFmwHtFuy6qZz
0 replies
Yingtrader7 Sep 24, 4:05 PM
$NSYS medical devices sector took a chjit, $ECOR $MOBI diving
3 replies
Trekingirl Sep 22, 7:29 PM
$ECOR Why have we doubled in the last 6 months? We're not expected to see positive EBITDA for another year, negative earnings per share and have limited cash on hand. Long-term shareholder and bullish for the long haul but something doesn't feel right at the moment. Thoughts anyone?
0 replies
Yingtrader7 Sep 22, 4:31 PM
$NSYS unbelievable that $ECOR
0 replies